Meta Pixel

News and Announcements

Revolutionary “No Joints” Composite Pipe Developer Set to Change Fluid-Transporation World-Wide

  • Published February 27, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Long Pipes Limited’s Fluid Highway™ is a patented, multi-award winning, pipe manufacturer. The company has developed the world’s first continuous “no joints” composite (fiberglass/carbon/basalt) pipe, made in the field for 1km or 1,000kms. Long Pipes‘ objective is to produce fluid transportation networks for the planet, which can be sold, leased, or used to control assets.

The company’s revolutionary technology is set to improve fluid distribution globally: – water, gas, oil, slurry; with a product that is more efficient, faster to install, cost effective, sustainable (lowest CO2 to produce), safe and reliable.

Long Pipes already has shareholders in Europe, Asia, and Australia, and is currently building capability with local modest sized projects before addressing the highly profitable $12Bn/yr global market.

The company is currently raising the final AUD$2m for this Round. The funds will allow Long Pipes to progress the commercialisation and expansion stages of the business.

Latest News & Announcements:

  • Previously secured $3M for technology development and in-field trials
  • Achieved previous milestones to move the company into commercialisation and the API Certification Process
  • World’s first continuous pipe, tested, installed, in network, for Harvey Water, 140kms south of Perth.
  • In November 2016 awarded:-
    • People’s Choice Award, with an audience of 220 people including representatives from the Australian Government, the UK Government, Investment institutions, banks and private investors.
    • The Energy Resources Award, from the Oil, Gas, Coal and Uranium Industry; was awarded by the General Manager, Jill Stejduhar, from National Energy Resources Australia (NERA).

To register your interest in Long Pipes, please click on the button below.

 

Capital Insights
The control layer for the electrified home

THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]

Capital Insights
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be  Attracting Big Pharma’s Attention

Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.

Join over 45,000+ sophisticated investors

Join Now